Results 191 to 200 of about 1,085,785 (298)
Reevaluating the relationship between COVID-19 and type 1 diabetes mellitus: Methodological considerations. [PDF]
Liang EM, Luo HC.
europepmc +1 more source
The increasing prevalence of dementia and related neurodegenerative diseases—including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis—poses a growing public health challenge. These conditions have traditionally been studied as isolated central nervous system disorders, but emerging evidence points to ...
Osayd Zohud +3 more
wiley +1 more source
A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus. [PDF]
Ebrahimpour Y +6 more
europepmc +1 more source
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono +3 more
wiley +1 more source
Bariatric/Metabolic Surgery in Type 1 and Type 2 Diabetes Mellitus
Mufide Nuran Akcay +2 more
doaj +1 more source
Current evidence and research gaps in menopause management in women with type 1 diabetes mellitus: a narrative review. [PDF]
Courtney A, Owens L.
europepmc +1 more source
Objective Antiseizure medication (ASM) use during pregnancy has increased over the past decade. However, evidence linking prenatal ASM exposure to neurodevelopmental disorders (NDDs) in offspring remains inconsistent. This study evaluated whether prenatal ASM exposure increases the risk of NDDs in children.
Odile Sheehy +13 more
wiley +1 more source
Estimating national prevalence of type 1 diabetes mellitus in children in Ireland using a novel simple approach: an observational study. [PDF]
Roche EF +6 more
europepmc +1 more source

